Neuromyelitis Optica Spectrum Disorder Market In Global
Neuromyelitis optica spectrum disorder (NMOSD), also known as Devic disease, is a chronic disorde ... Read More
Myomectomy a surgical procedure for the removal uterine fibroids. Uterine fibroids are common noncancerous growth in the uterus of women at their child bearing age, causing symptoms such as heavy bleeding during menstrual cycle, increased menstrual cramping, pain in pelvis or lower back, and swelling enlargement of the abdomen. Myomectomy differs from hysterectomy. During myomectomy, the surgeons remove only the fibroids in the uterus while in hysterectomy entire uterus is removed. This procedure preserves the chances of women getting pregnant. There are four types of myomectomy namely; abdominal, hysteroscopic, laparoscopic, and robotic. Results of myomectomy are found to be better and women report improvement in fibroid symptoms, such as heavy menstrual bleeding and pelvic pressure.
This report contains market size and forecasts of Myomectomy in Global, including the following market information:
Global Myomectomy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Myomectomy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Abdominal Myomectomy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Myomectomy include Medtronic, Stryker Corporation, CONMED Corporation, INSIGHTEC, CooperSurgical Inc., Hologic, Inc., Intuitive Surgical, Karl Storz and B. Braun Melsungen AG. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Myomectomy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Myomectomy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Myomectomy Market Segment Percentages, by Type, 2021 (%)
Abdominal Myomectomy
Hysteroscopic Myomectomy
Laparoscopic Myomectomy
Global Myomectomy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Myomectomy Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Myomectomy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Myomectomy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Myomectomy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Myomectomy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Stryker Corporation
CONMED Corporation
INSIGHTEC
CooperSurgical Inc.
Hologic, Inc.
Intuitive Surgical
Karl Storz
B. Braun Melsungen AG
Neuromyelitis optica spectrum disorder (NMOSD), also known as Devic disease, is a chronic disorde ... Read More
CDKL5 deficiency disorder (CDD) is a rare developmental epileptic encephalopathy (DEE), X-linked ... Read More
Epilepsy is a disorder of the brain characterized by repeated seizures. A seizure is usually defi ... Read More
Developmental and Epileptic Encephalopathies (DEE) consists of several types of severe brain diso ... Read More